Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90

1.
2.

Sentinel lymph node positivity in patients undergoing mastectomies for ductal carcinoma in situ (DCIS).

Price A, Schnabel F, Chun J, Kaplowitz E, Goodgal J, Guth A, Axelrod D, Shapiro R, Mema E, Moy L, Darvishian F, Roses D.

Breast J. 2020 Jan 20. doi: 10.1111/tbj.13737. [Epub ahead of print]

PMID:
31957944
3.

The relationship of breast density in mammography and magnetic resonance imaging in women with triple negative breast cancer.

Mema E, Schnabel F, Chun J, Kaplowitz E, Price A, Goodgal J, Moy L.

Eur J Radiol. 2020 Jan 7;124:108813. doi: 10.1016/j.ejrad.2020.108813. [Epub ahead of print]

PMID:
31927471
4.

A Nomogram to Predict Factors Associated with Lymph Node Metastasis in Ductal Carcinoma In Situ with Microinvasion.

Gooch JC, Schnabel F, Chun J, Pirraglia E, Troxel AB, Guth A, Shapiro R, Axelrod D, Roses D.

Ann Surg Oncol. 2019 Dec;26(13):4302-4309. doi: 10.1245/s10434-019-07750-9. Epub 2019 Sep 16.

PMID:
31529311
5.

Drivers of productivity and its temporal stability in a tropical tree diversity experiment.

Schnabel F, Schwarz JA, Dănescu A, Fichtner A, Nock CA, Bauhus J, Potvin C.

Glob Chang Biol. 2019 Dec;25(12):4257-4272. doi: 10.1111/gcb.14792. Epub 2019 Sep 5.

PMID:
31486578
6.

Pregnancy-associated breast cancer in a contemporary cohort of newly diagnosed women.

Gooch JC, Chun J, Kaplowitz E, Guth A, Axelrod D, Shapiro R, Roses D, Schnabel F.

Breast J. 2019 Aug 25. doi: 10.1111/tbj.13510. [Epub ahead of print]

PMID:
31448522
7.

ASO Author Reflections: Margin Analysis and Breast-Conserving Surgery.

Gooch JC, Schnabel F.

Ann Surg Oncol. 2019 Dec;26(Suppl 3):678-679. doi: 10.1245/s10434-019-07671-7. Epub 2019 Aug 6. No abstract available.

PMID:
31388775
8.

Genetic testing for hereditary breast and ovarian cancer and the USPSTF recommendations.

Wood ME, Garber JE, Isaacs C, Masood S, Bedrosian I, Tung N, Chun J, Schnabel FR, Arun BK; International Society of Cancer Risk Assessment and Management.

Breast J. 2019 Jul;25(4):575-577. doi: 10.1111/tbj.13292. No abstract available.

PMID:
31280501
9.

Tumor-Infiltrating Lymphocytes in a Contemporary Cohort of Women with Ductal Carcinoma In Situ (DCIS).

Darvishian F, Ozerdem U, Adams S, Chun J, Pirraglia E, Kaplowitz E, Guth A, Axelrod D, Shapiro R, Price A, Troxel A, Schnabel F, Roses D.

Ann Surg Oncol. 2019 Oct;26(10):3337-3343. doi: 10.1245/s10434-019-07562-x. Epub 2019 Jun 25.

PMID:
31240590
10.

Incidental extramedullary hematopoiesis of an axillary lymph node: A diagnostic pitfall in sentinel lymph node biopsy.

Lytle A, Schnabel F, Ozerdem U.

Breast J. 2019 Sep;25(5):986-987. doi: 10.1111/tbj.13404. Epub 2019 Jun 11. No abstract available.

PMID:
31187557
11.

Breast Density in a Contemporary Cohort of Women With Ductal Carcinoma In Situ (DCIS).

Gooch JC, Chun J, Kaplowitz E, Kurz E, Guth A, Lee J, Schnabel F.

Ann Surg Oncol. 2019 Oct;26(11):3472-3477. doi: 10.1245/s10434-019-07479-5. Epub 2019 May 30.

PMID:
31147991
12.

Surgical treatment of young women with breast cancer: Public vs private hospitals.

Patel A, Wang WJ, Warnack E, Joseph KA, Schnabel F, Axelrod D, Dhage S.

Breast J. 2019 Jul;25(4):625-630. doi: 10.1111/tbj.13294. Epub 2019 May 9.

PMID:
31074047
13.

Genomic testing in early stage invasive male breast cancer: An NCDB analysis from 2008 to 2014.

Dubrovsky E, Raymond S, Chun J, Fong A, Patel N, Guth A, Schnabel F.

Breast J. 2019 May;25(3):425-433. doi: 10.1111/tbj.13235.

PMID:
31025517
14.

Oncologic Trends, Outcomes, and Risk Factors for Locoregional Recurrence: An Analysis of Tumor-to-Nipple Distance and Critical Factors in Therapeutic Nipple-Sparing Mastectomy.

Frey JD, Salibian AA, Lee J, Harris K, Axelrod DM, Guth AA, Shapiro RL, Schnabel FR, Karp NS, Choi M.

Plast Reconstr Surg. 2019 Jun;143(6):1575-1585. doi: 10.1097/PRS.0000000000005600.

PMID:
30907805
15.

The Relationship of Breast Density and Positive Lumpectomy Margins.

Gooch JC, Yoon E, Chun J, Kaplowitz E, Jubas T, Guth A, Axelrod D, Shapiro R, Darvishian F, Schnabel F.

Ann Surg Oncol. 2019 Jun;26(6):1729-1736. doi: 10.1245/s10434-019-07295-x. Epub 2019 Mar 19.

PMID:
30888516
16.

Down syndrome phenotype in a boy with a mosaic microduplication of chromosome 21q22.

Schnabel F, Smogavec M, Funke R, Pauli S, Burfeind P, Bartels I.

Mol Cytogenet. 2018 Dec 29;11:62. doi: 10.1186/s13039-018-0410-4. eCollection 2018.

17.

Ductal carcinoma in situ on core needle biopsy only with no residual disease at surgery.

Dubrovsky E, Nguyen P, Chun J, Schwartz S, Raymond S, Guth A, Schnabel F, Gerber NK.

Breast J. 2018 Nov;24(6):971-975. doi: 10.1111/tbj.13095. Epub 2018 Jul 30.

PMID:
30062749
18.

Post-mastectomy Radiation Therapy in Breast Cancer Patients with Nodal Micrometastases.

Wu SP, Tam M, Shaikh F, Lee A, Chun J, Schnabel F, Guth A, Adams S, Schreiber D, Oh C, Gerber NK.

Ann Surg Oncol. 2018 Sep;25(9):2620-2631. doi: 10.1245/s10434-018-6632-1. Epub 2018 Jul 9.

PMID:
29987606
19.

Temperature stability of static and dynamic properties of 1.55 µm quantum dot lasers.

Abdollahinia A, Banyoudeh S, Rippien A, Schnabel F, Eyal O, Cestier I, Kalifa I, Mentovich E, Eisenstein G, Reithmaier JP.

Opt Express. 2018 Mar 5;26(5):6056-6066. doi: 10.1364/OE.26.006056.

PMID:
29529801
20.

Non-BRCA1/2 Breast Cancer Susceptibility Genes: A New Frontier with Clinical Consequences for Plastic Surgeons.

Frey JD, Salibian AA, Schnabel FR, Choi M, Karp NS.

Plast Reconstr Surg Glob Open. 2017 Nov 20;5(11):e1564. doi: 10.1097/GOX.0000000000001564. eCollection 2017 Nov.

21.

Clinical Characteristics in Patients with Triple Negative Breast Cancer.

Yeh J, Chun J, Schwartz S, Wang A, Kern E, Guth AA, Axelrod D, Shapiro R, Schnabel F.

Int J Breast Cancer. 2017;2017:1796145. doi: 10.1155/2017/1796145. Epub 2017 Aug 17.

22.

Multi-institutional Evaluation of Women at High Risk of Developing Breast Cancer.

Hermel DJ, Wood ME, Chun J, Rounds T, Sands M, Schwartz S, Schnabel FR.

Clin Breast Cancer. 2017 Oct;17(6):427-432. doi: 10.1016/j.clbc.2017.04.005. Epub 2017 Apr 14.

PMID:
28539235
23.

Breast Cancer Risk Assessment and Screening in Transgender Patients.

Pivo S, Montes J, Schwartz S, Chun J, Kiely D, Hazen A, Schnabel F.

Clin Breast Cancer. 2017 Aug;17(5):e225-e227. doi: 10.1016/j.clbc.2016.08.003. Epub 2016 Aug 25. No abstract available.

PMID:
28428098
24.

The Relationship of Race, Oncotype DX, and Ki67 in a Population Highly Screened For Breast Cancer.

Guth AA, Chun Kim J, Schwartz S, Montes J, Snyder RA, Axelrod D, Schnabel F.

Breast J. 2017 Mar;23(2):177-181. doi: 10.1111/tbj.12781.

PMID:
28299888
25.

Breast Cancer Profile among Patients with a History of Chemoprevention.

Schnabel FR, Pivo S, Chun J, Schwartz S, Refinetti AP, Axelrod D, Guth A.

Int J Breast Cancer. 2016;2016:9216375. doi: 10.1155/2016/9216375. Epub 2016 Dec 18.

26.

The relationship of obesity, mammographic breast density, and magnetic resonance imaging in patients with breast cancer.

Gillman J, Chun J, Schwartz S, Schnabel F, Moy L.

Clin Imaging. 2016 Nov - Dec;40(6):1167-1172. doi: 10.1016/j.clinimag.2016.08.009. Epub 2016 Aug 12.

PMID:
27572282
27.

A Prospective, Single Arm, Multi-site, Clinical Evaluation of a Nonradioactive Surgical Guidance Technology for the Location of Nonpalpable Breast Lesions during Excision.

Cox CE, Russell S, Prowler V, Carter E, Beard A, Mehindru A, Blumencranz P, Allen K, Portillo M, Whitworth P, Funk K, Barone J, Norton D, Schroeder J, Police A, Lin E, Combs F, Schnabel F, Toth H, Lee J, Anglin B, Nguyen M, Canavan L, Laidley A, Warden MJ, Prati R, King J, Shivers SC.

Ann Surg Oncol. 2016 Oct;23(10):3168-74. doi: 10.1245/s10434-016-5405-y. Epub 2016 Jul 28.

PMID:
27469121
28.

A Web- and Mobile-Based Intervention for Women Treated for Breast Cancer to Manage Chronic Pain and Symptoms Related to Lymphedema: Randomized Clinical Trial Rationale and Protocol.

Fu MR, Axelrod D, Guth A, Scagliola J, Rampertaap K, El-Shammaa N, Fletcher J, Zhang Y, Qiu JM, Schnabel F, Hiotis K, Wang Y, D'Eramo Melkus G.

JMIR Res Protoc. 2016 Jan 21;5(1):e7. doi: 10.2196/resprot.5104.

29.

Oncologic outcomes after nipple-sparing mastectomy: A single-institution experience.

Frey JD, Alperovich M, Kim JC, Axelrod DM, Shapiro RL, Choi M, Schnabel FR, Karp NS, Guth AA.

J Surg Oncol. 2016 Jan;113(1):8-11. doi: 10.1002/jso.24097. Epub 2015 Dec 2.

PMID:
26628318
30.

Nipple-sparing Mastectomy and Sub-areolar Biopsy: To Freeze or not to Freeze? Evaluating the Role of Sub-areolar Intraoperative Frozen Section.

Alperovich M, Choi M, Karp NS, Singh B, Ayo D, Frey JD, Roses DF, Schnabel FR, Axelrod DM, Shapiro RL, Guth AA.

Breast J. 2016 Jan-Feb;22(1):18-23. doi: 10.1111/tbj.12517. Epub 2015 Oct 28.

PMID:
26510917
31.

The relationship of breast density in mammography and magnetic resonance imaging in high-risk women and women with breast cancer.

Albert M, Schnabel F, Chun J, Schwartz S, Lee J, Klautau Leite AP, Moy L.

Clin Imaging. 2015 Nov-Dec;39(6):987-92. doi: 10.1016/j.clinimag.2015.08.001. Epub 2015 Aug 6.

32.

Cancer risk assessment using genetic panel testing: considerations for clinical application.

Hiraki S, Rinella ES, Schnabel F, Oratz R, Ostrer H.

J Genet Couns. 2014 Aug;23(4):604-17. doi: 10.1007/s10897-014-9695-6. Epub 2014 Mar 7.

PMID:
24599651
33.

A randomized prospective study of lumpectomy margin assessment with use of MarginProbe in patients with nonpalpable breast malignancies.

Schnabel F, Boolbol SK, Gittleman M, Karni T, Tafra L, Feldman S, Police A, Friedman NB, Karlan S, Holmes D, Willey SC, Carmon M, Fernandez K, Akbari S, Harness J, Guerra L, Frazier T, Lane K, Simmons RM, Estabrook A, Allweis T.

Ann Surg Oncol. 2014 May;21(5):1589-95. doi: 10.1245/s10434-014-3602-0. Epub 2014 Mar 5.

34.

Screening prior to Breast Cancer Diagnosis: The More Things Change, the More They Stay the Same.

Friedman EB, Chun J, Schnabel F, Schwartz S, Law S, Billig J, Ivanoff E, Moy L, Axelrod D, Guth A.

Int J Breast Cancer. 2013;2013:327567. doi: 10.1155/2013/327567. Epub 2013 Sep 18.

35.

Genetic variants associated with breast cancer risk for Ashkenazi Jewish women with strong family histories but no identifiable BRCA1/2 mutation.

Rinella ES, Shao Y, Yackowski L, Pramanik S, Oratz R, Schnabel F, Guha S, LeDuc C, Campbell CL, Klugman SD, Terry MB, Senie RT, Andrulis IL, Daly M, John EM, Roses D, Chung WK, Ostrer H.

Hum Genet. 2013 May;132(5):523-36. doi: 10.1007/s00439-013-1269-4. Epub 2013 Jan 25.

36.

Pregnancy-associated breast cancer and increased risk of pregnancy-associated recurrence: a case report.

Schnabel F, Billig J, Cimeno A, Chun J.

J Med Case Rep. 2012 Jun 7;6:144. doi: 10.1186/1752-1947-6-144.

37.

The relationship of mammographic density and age: implications for breast cancer screening.

Checka CM, Chun JE, Schnabel FR, Lee J, Toth H.

AJR Am J Roentgenol. 2012 Mar;198(3):W292-5. doi: 10.2214/AJR.10.6049.

PMID:
22358028
38.

Influence of a fat-rich meal on bioavailability of extended-release and immediate-release propiverine.

Siegmund W, Siegert J, Richter K, Schnabel F, Feustel C, Kirch W.

J Clin Pharmacol. 2012 May;52(5):681-90. doi: 10.1177/0091270011401260. Epub 2011 May 6.

PMID:
21551317
39.

Efficacy of propiverine ER with or without α-blockers related to maximum urinary flow rate in adult men with OAB: results of a 12-week, multicenter, non-interventional study.

Oelke M, Murgas S, Baumann I, Schnabel F, Michel MC.

World J Urol. 2011 Apr;29(2):217-23. doi: 10.1007/s00345-011-0654-7. Epub 2011 Feb 16.

40.

Pharmacokinetics and pharmacodynamics of propiverine in children aged between 5 and 10 years with symptoms of overactive bladder.

Siegmund W, Sillén U, Läckgren G, Schnabel F, Mürtz G, Feustel C.

Clin Pharmacokinet. 2010 May;49(5):335-42. doi: 10.2165/11319990-000000000-00000.

PMID:
20384395
41.

The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study.

Tager FA, McKinley PS, Schnabel FR, El-Tamer M, Cheung YK, Fang Y, Golden CR, Frosch ME, Habif U, Mulligan MM, Chen IS, Hershman DL.

Breast Cancer Res Treat. 2010 Aug;123(1):25-34. doi: 10.1007/s10549-009-0606-8. Epub 2009 Nov 6. Erratum in: Breast Cancer Res Treat. 2011 Feb;126(1):271-2.

PMID:
19894112
42.

Breast cancer risk factors in younger and older women.

Chun J, Pocock B, Joseph KA, El-Tamer M, Klein L, Schnabel F.

Ann Surg Oncol. 2009 Jan;16(1):96-9. doi: 10.1245/s10434-008-0176-8. Epub 2008 Nov 1.

PMID:
18979140
43.

Assessing a Bayesian risk prediction model in a high-risk breast cancer population.

Chun J, Schnabel F, Ogunyemi O.

AMIA Annu Symp Proc. 2007 Oct 11:913.

PMID:
18694013
44.

Disparities in time to definitive surgical treatment between black and white women diagnosed with ductal carcinoma in situ.

Pocock B, Nash S, Klein L, El-Tamer M, Schnabel FR, Joseph KA.

Am J Surg. 2007 Oct;194(4):521-3.

PMID:
17826071
45.

Therapeutic options for Paget's disease: A single institution long-term follow-up study.

Joseph KA, Ditkoff BA, Estabrook A, El-Tamer MB, Banarjee S, Schnabel FR.

Breast J. 2007 Jan-Feb;13(1):110-1. No abstract available.

PMID:
17214812
46.

Long-term outcomes of malignant phyllodes tumors patients: an institutional experience.

Fou A, Schnabel FR, Hamele-Bena D, Wei XJ, Cheng B, El Tamer M, Klein L, Joseph KA.

Am J Surg. 2006 Oct;192(4):492-5.

PMID:
16978957
47.

Predictors of breast cancer development in a high-risk population.

Chun J, El-Tamer M, Joseph KA, Ditkoff BA, Schnabel F.

Am J Surg. 2006 Oct;192(4):474-7.

PMID:
16978952
48.

Propiverine compared to oxybutynin in neurogenic detrusor overactivity--results of a randomized, double-blind, multicenter clinical study.

Stöhrer M, Mürtz G, Kramer G, Schnabel F, Arnold EP, Wyndaele JJ; Propiverine Investigator Group.

Eur Urol. 2007 Jan;51(1):235-42. Epub 2006 May 2.

PMID:
16698176
49.

Cutaneous subareolar leiomyoma: a rare clinical entity.

Joseph KA, Shutter J, El-Tamer M, Schnabel F.

Breast J. 2005 Nov-Dec;11(6):501-2. No abstract available.

PMID:
16297114
50.

Supplemental Content

Loading ...
Support Center